In vitro recognition of fusion vaccine by T-cells

This test, described for glioblastoma, performed with PBMC from newly diagnosed glioblastoma patients will verify the ability of tumour-specific T-cells to recognize the fusion vaccine. Data will be made available.

BruCells has met with the Dutch MEB for a Scientific Advice Meeting on January 10, 2008 in The Hague.
The Dutch authorities consider that the proposed in-vitro pre-clinical tests are adequate to check the pharmacodynamic activity of the fusion vaccines and that no animal model tests would be necessary.

created over 14 years ago (24 February 2010)    last modified over 11 years ago (20 May 2013)   [ RDF ]   [ RelFinder ]